| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/11/2004 | EP1443956A2 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis |
| 08/11/2004 | EP1443947A1 Use of defibrinated blood for the manufacture of a hemoglobin-based oxygen carrier |
| 08/11/2004 | EP1443913A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/11/2004 | EP1443816A2 Methods of treating disorders related to apoe |
| 08/11/2004 | EP1379278A4 Method of inducing proliferation of retinal stem cells |
| 08/11/2004 | EP1042471B1 Mammalian edg-7 receptor homologs |
| 08/11/2004 | EP1019489B1 Application of shear flow stress to chondrocytes |
| 08/11/2004 | EP1002080B9 Fluorescent proteins as cell-type specific reporter |
| 08/11/2004 | EP0977859B1 The neurotrophic factor nnt-1 |
| 08/11/2004 | EP0927354B1 DIAGNOSTIC METHOD FOR DETECTION OF MOLECULAR FORMS OF EOSINOPHILIC CATIONIC PROTEIN (iso-ECPs) |
| 08/11/2004 | EP0894135B1 Multivalent and multispecific antigen-binding protein |
| 08/11/2004 | EP0862627B1 Neuropeptide y-y5 receptor |
| 08/11/2004 | EP0821728B1 Tie-2 ligands, methods of making and uses thereof |
| 08/11/2004 | EP0779922B1 Modified human c3 proteins |
| 08/11/2004 | EP0749472B1 Extracorporeal cell culture and transplantation kits |
| 08/11/2004 | EP0604560B1 Human cyclin e |
| 08/11/2004 | EP0575464B1 Modified factor vii |
| 08/11/2004 | CN1520516A T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 08/11/2004 | CN1520424A Immunoglobulins 2 |
| 08/11/2004 | CN1520312A T cell induced tissue repair and regeneration |
| 08/11/2004 | CN1520306A Methods and devices for tissure repair |
| 08/11/2004 | CN1520304A Xenogenic oligo of or/and polyribonucleotides as agents for treatment of malignant twnours |
| 08/11/2004 | CN1520256A Use of follistatin to increase muscle mass |
| 08/11/2004 | CN1519324A Method for fast obtaining transgenic plant of potato |
| 08/11/2004 | CN1519314A Low temperature method for conserving ture skin obtained from tissue engineering |
| 08/11/2004 | CN1519313A Method for breaking up microbe and vegetable cell |
| 08/11/2004 | CN1161615C Time for predicting taking out of non-fertilisable ova, its method and application |
| 08/11/2004 | CN1161474C Improvement relating to the specificity of gene expression |
| 08/11/2004 | CN1161471C Orotidine 5'-phosphate decarboxylase-gene, gene construct containing said gene and utilization thereof |
| 08/11/2004 | CN1161468C MPL ligand analogs |
| 08/11/2004 | CN1161465C Chimeric proteins for use in transport of selected substance into cells |
| 08/11/2004 | CN1161457C In vitro reconstituted human erythrocyte, its preparation and application in blood substitute material |
| 08/11/2004 | CN1161382C Production of recombination human lactoferritin |
| 08/11/2004 | CN1161129C I(ex vivo) treatment of allogeneic and xanogeneic T-cells with gp39 antagonists |
| 08/10/2004 | US6775574 Method and system for myocardial infarction repair |
| 08/10/2004 | US6774284 Exhibit senescence-induced expression, transgenic plants containing polynucleotides in antisense orientation |
| 08/10/2004 | US6774281 By transforming a plant with a polynucleotide sequence comprising a pathogen inducible promoter which regulates the expression of a plant signal transduction protein which when expressed gives rise to a hypersensitive response in plants |
| 08/10/2004 | US6774224 ULBP DNA and polypeptides |
| 08/10/2004 | US6774220 Compounds having lectinic properties and their biological applications |
| 08/10/2004 | US6774217 Use of fragile histidine triad gene (fhit) genes and their encoded proteins as diagnostic and therapeutic reagents for the detection and treatment of disease states associated with cell overproliferation |
| 08/10/2004 | US6774216 Antibody for use in diagnosis and treatment of immunological, inflammatory and nervous system disorders |
| 08/10/2004 | US6774214 Monocyte-derived homolog of FDF03 protein |
| 08/10/2004 | US6774120 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 08/10/2004 | US6774116 Prodrugs via acylation with cinnamate |
| 08/10/2004 | US6774107 Protein for blocking platelet adhesion |
| 08/10/2004 | US6773919 Transcription enhancers such as serine protease inhibitor-growth hormone responsive element |
| 08/10/2004 | US6773915 Detecting antibodies; culture product |
| 08/10/2004 | US6773909 Concentration and lysis of adenovirus-infected cells in a single unit operation |
| 08/10/2004 | US6773903 Laser cell purification system |
| 08/10/2004 | US6773893 Human ABC1 promoter and assays based thereon |
| 08/10/2004 | US6773889 Detection of sequence polymorphisms in sample; obtain wild type plant nucleotide sequences, determine sequence, isolate nucleotide sequences from sample, determine adjustments in sequences, presence of adjustments indicate polymorphisms |
| 08/10/2004 | US6773879 Recovering plant nucleotide sequences from sample; obtain plant sample, extract nucleotide sequences, digest, perform genome subtraction, screen for polymorphic sequences |
| 08/10/2004 | US6773713 Providing a negative mold having a defined shape; suspending isolated tissue precursor cells in a hydrogel, introducing suspension into the mold, inducing gelation to solidify liquid hydrogel-precursor cell to form living tissue |
| 08/10/2004 | US6773709 Chicken embryo lethal (CELO) virus |
| 08/10/2004 | US6773706 Enzymatic polypeptide for use in the diagnosis and treatment of bacterial infections |
| 08/10/2004 | US6773701 Expression enhancer for protein synthesis inhibitory genes |
| 08/10/2004 | US6773669 Flow electroporation chamber and method |
| 08/10/2004 | CA2260365C Differentiation-suppressive polypeptide |
| 08/10/2004 | CA2221275C Isolation of cells from organ tissue using sonication |
| 08/10/2004 | CA2199663C In vitro maturation and fertilization of mammalian oocytes |
| 08/07/2004 | CA2457105A1 Pharmaceutical preparation for the improved treatment of blood-clotting disorders |
| 08/05/2004 | WO2004065618A2 Methods and devices for monitoring cellular metabolism in microfluidic cell-retaining chambers |
| 08/05/2004 | WO2004065616A2 Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications |
| 08/05/2004 | WO2004065605A1 β1,3-N-ACETYL-D-GALACTOSAMINE TRANSFERASE PROTEIN, NUCLEIC ACID ENCODING THE SAME AND METHOD OF EXAMINING CANCERATION USING THE SAME |
| 08/05/2004 | WO2004065599A1 Lrp4/CORIN DOPAMINE-PRODUCING NEURON PROLIFERATION PRECURSOR CELL MARKER |
| 08/05/2004 | WO2004065590A2 Activation and expansion of t cells |
| 08/05/2004 | WO2004065589A1 Method of preparing cell for transplantation |
| 08/05/2004 | WO2004065588A1 A process of characterization of hepatocytes from goat |
| 08/05/2004 | WO2004065587A1 Compositions and processes using sirna, amphipathic compounds and polycations |
| 08/05/2004 | WO2004065586A1 Three-dimenstional cell construct and method of constructing the same |
| 08/05/2004 | WO2004065585A1 A method for reproducing conifers by somatic embryogenesis using galactose containing compounds as a carbon and energy source |
| 08/05/2004 | WO2004065580A2 Mesecnhymal stem cells as a vehicle for ion channel transfer in syncytial structures |
| 08/05/2004 | WO2004065564A2 Electromagnetic activation of gene expression and cell growth |
| 08/05/2004 | WO2004065554A2 Human saa3 nucleic acid molecule, protein, and methods of use for same |
| 08/05/2004 | WO2004065552A2 Cell-based therapies for diabetes mellitus and other glucose intolerant states |
| 08/05/2004 | WO2004065422A2 Cancerous disease modifying antibodies |
| 08/05/2004 | WO2004065421A1 Cancerous disease modifying antibodies |
| 08/05/2004 | WO2004065420A1 Cancerous disease modifying antibodies |
| 08/05/2004 | WO2004065419A1 Antibody and use thereof |
| 08/05/2004 | WO2004065408A2 Enhancement of humoral immune responses using a novel myeloid accessory cell |
| 08/05/2004 | WO2004064863A1 Treatment of autoimmune diseases using an activator for the notch signaling pathway |
| 08/05/2004 | WO2004064785A2 Cancer therapy sensitizer |
| 08/05/2004 | WO2004064750A2 Improved constructs for expressing lysosomal polypeptides |
| 08/05/2004 | WO2004064612A2 Regulation of tgf-b signaling by tomoregulin |
| 08/05/2004 | WO2004047860A3 Cells not presenting antigen for suppressing pathological immune reactions |
| 08/05/2004 | WO2004031276A8 Method of inducing maturation of dendritic cells and uses therefor |
| 08/05/2004 | WO2004028339A3 Treatment of patients with multiple sclerosis based on gene expression changes in central nervous system tissues |
| 08/05/2004 | WO2004028243A3 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 08/05/2004 | WO2004024875A3 Mammalian megakaryocyte progenitor cell |
| 08/05/2004 | WO2003104393A3 Three dimensional vaginal tissue model containing immune cells |
| 08/05/2004 | WO2003100011A3 Generation of histocompatible tissues using nuclear transplantation |
| 08/05/2004 | WO2003063581A3 Compositions and methods for increasing animal size and growth rate |
| 08/05/2004 | WO2003057830A3 Compositions and methods for hydroxylating epothilones |
| 08/05/2004 | WO2003044045A3 Peptides promoting cell adherence, growth and secretion |
| 08/05/2004 | WO2003042359A3 Histamine receptor h3 polynucleotides |
| 08/05/2004 | WO2003039462A3 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies |
| 08/05/2004 | WO2003029411A3 Novel cyclooxygenase variants and methods of use |
| 08/05/2004 | WO2003024191A3 Antibodies that bind to cancer-associated antigen cytokeratin 8 and methods of use thereof |
| 08/05/2004 | WO2003022227A3 Antisense modulation of vascular endothelial growth factor receptor-1 expression |
| 08/05/2004 | WO2002081648A3 Synthesis and secretion of recombinant lysosomal enzymes by liver |